Biotech1 week ago
Laminar Pharma Raises 5.9 Million in a New Round of Financing
Laminar Pharma raised €5.9 million, led by the Matutes family, for its growth and launch of anti-tumor drug LAM 561, aimed at glioblastoma treatment. Additional investors...